Sensitivity of Quantitative Metrics Derived from DCE MRI and a Pharmacokinetic Model to Image Quality and Acquisition Parameters

Academic Radiology

Volumn 17, Issue 4, 2010, Pages 468-478

  Cao, Yue ^a,b   Li, Diana ^a   Shen, Zhou ^a   Normolle, Daniel ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

DCE MRI; imaging biomarker; pharmacokinetic model; stability; therapy assessment

Indexed keywords

CONTRAST MEDIUM;

ARTICLE; BLOOD SAMPLING; CONTRAST ENHANCEMENT; DRUG BLOOD LEVEL; HUMAN; HUMAN TISSUE; IMAGE QUALITY; LONGITUDINAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA VOLUME; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELIABILITY; SENSITIVITY ANALYSIS; SIGNAL NOISE RATIO;

ALGORITHMS; COMPUTER SIMULATION; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MODELS, BIOLOGICAL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 77649094345     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2009.10.021     Document Type: Article

References (19)

1. Galbraith S.M., Rustin G.J., Lodge M.A., et al. Effects of 5,6-dimethylxanthenone-4-acetic acid on human tumor microcirculation assessed by dynamic contrast-enhanced magnetic resonance imaging. J Clin Oncol 20 (2002) 3826-3840
2. Morgan B., Thomas A.L., Drevs J., et al. Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase I studies. J Clin Oncol 21 (2003) 3955-3964
3. Rugo H.S., Herbst R.S., Liu G., et al. Phase I trial of the oral antiangiogenesis agent AG-013736 in patients with advanced solid tumors: pharmacokinetic and clinical results. J Clin Oncol 23 (2005) 5474-5483
4. Sorensen A.G., Batchelor T.T., Zhang W.T., et al. A "vascular normalization index" as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients. Cancer Res 69 (2009) 5296-5300
5. Cao Y., Popovtzer A., Li D., et al. Early prediction of outcome in advanced head-and-neck cancer based on tumor blood volume alterations during therapy: a prospective study. Int J Radiat Oncol Biol Phys 72 (2008) 1287-1290
6. Cao Y., Tsien C.I., Sundgren P., et al. DCE MRI as a biomarker for prediction of radiation-induced neurocognitive dysfunction. Clin Cancer Res 15 (2009) 1747-1754
7. Henderson E., Rutt B.K., and Lee T.Y. Temporal sampling requirements for the tracer kinetics modeling of breast disease. Magn Reson Imaging 16 (1998) 1057-1073
8. Calamante F., Gadian D.G., and Connelly A. Delay and dispersion effects in dynamic susceptibility contrast MRI: simulations using singular value decomposition. Magn Reson Med 44 (2000) 466-473
9. Cheng H.L. Investigation and optimization of parameter accuracy in dynamic contrast-enhanced MRI. J Magn Reson Imaging 28 (2008) 736-743
10. Peeters F., Annet L., Hermoye L., and Van Beers B.E. Inflow correction of hepatic perfusion measurements using T1-weighted, fast gradient-echo, contrast-enhanced MRI. Magn Reson Med 51 (2004) 710-717
11. Singh A., Rathore R.K., Haris M., et al. Improved bolus arrival time and arterial input function estimation for tracer kinetic analysis in DCE-MRI. J Magn Reson Imaging 29 (2009) 166-176
12. Jackson A., Jayson G.C., Li K.L., et al. Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting glioma. Br J Radiol 76 (2003) 153-162
13. Galbraith S.M., Lodge M.A., Taylor N.J., et al. Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis. NMR Biomed 15 (2002) 132-142
14. Padhani A.R., Hayes C., Landau S., et al. Reproducibility of quantitative dynamic MRI of normal human tissues. NMR Biomed 15 (2002) 143-153
15. Yang C., Karczmar G.S., Medved M., et al. Reproducibility assessment of a multiple reference tissue method for quantitative dynamic contrast enhanced-MRI analysis. Magn Reson Med 61 (2009) 851-859
16. Lopata R.G., Backes W.H., van den Bosch P.P., et al. On the identifiability of pharmacokinetic parameters in dynamic contrast-enhanced imaging. Magn Reson Med 58 (2007) 425-429
17. Tofts P.S., Brix G., Buckley D.L., et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10 (1999) 223-232
18. Ewing J.R., Knight R.A., Nagaraja T.N., et al. Patlak plots of Gd-DTPA MRI data yield blood-brain transfer constants concordant with those of 14C-sucrose in areas of blood-brain opening. Magn Reson in Med 50 (2003) 283-292
19. Cao Y. Development of Image Software Tools for Radiation Therapy Assessment. Medical Physics 32 (2005) 2136